Association Between the Expression of MicroRNA-125b and Survival in Patients With Acute Coronary Syndrome and Coronary Multivessel Disease

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Jul 25

PMID 35872885

Authors

Gloria M Gager

Ceren Eyileten

Marek Postula

Aleksandra Gasecka

Joanna Jarosz-Popek

Georg Gelbenegger

Bernd Jilma

Irene Lang

Jolanta Siller-Matula

Affiliations

Soon will be listed here.

Abstract

Background: MicroRNAs (miRNA, miR) have an undeniable physiological and pathophysiological significance and act as promising novel biomarkers. The aim of the study was to investigate blood-derived miRNAs and their association with long-term all-cause mortality in patients with multivessel disease (MVD) suffering from acute coronary syndrome (ACS).

Materials And Methods: This study was an observational prospective study, which included 90 patients with MVD and ACS. Expression of miR-125a, miR-125b, and miR-223 was analysed by polymerase chain reaction (PCR). Patients were followed-up for a median of 7.5 years. All-cause mortality was considered as the primary endpoint. Adjusted Cox-regression analysis was performed for prediction of events.

Results: Elevated expression of miR-125b (>4.6) at the time-point of ACS was associated with increased long-term all-cause mortality (adjusted [adj.] hazard ratio [HR] = 11.26, 95% confidence interval [95% CI]: 1.15-110.38; = 0.038). The receiver operating characteristic (ROC) analysis showed a satisfactory c-statistics for miR-125b for the prediction of long-term all-cause mortality (area under the curve [AUC] = 0.76, 95% CI: 0.61-0.91; = 0.034; the negative predictive value of 98%). Kaplan-Meier time to event analysis confirmed an early separation of the survival curves between patients with high vs low expression of miR-125b ( = 0.003). An increased expression of miR-125a and miR-223 was found in patients with non-ST-segment elevation ACS (NSTE-ACS) as compared to those with ST-segment elevation myocardial infarction (STEMI) ( = 0.043 and = 0.049, respectively) with no difference in the expression of miR-125b between the type of ACS.

Conclusion: In this hypothesis generating study, lower values of miR-125b were related to improved long-term survival in patients with ACS and MVD. Larger studies are needed to investigate whether miR-125b can be used as a suitable predictor for long-term all-cause mortality.

Citing Articles

Circulating Microvesicles Enriched in miR-126-5p and miR-223-3p: Potential Biomarkers in Acute Coronary Syndrome.

Hernandez-Lopez J, Flores-Garcia M, Garcia-Flores E, Cazarin-Santos B, Pena-Duque M, Sanchez-Munoz F Biomedicines. 2025; 13(2).

PMID: 40002921 PMC: 11852751. DOI: 10.3390/biomedicines13020510.

Correlation of MicroRNA-125b, Sirtuin, and Signal Transducer and Activator of Transcription 3 with Biochemical Parameters and Risk Factors in Atherosclerosis Patients.

Mirderikvand A, Shahsavari G, Moayyed Kazemi A, Ahmadpour F, Yalameha B Rep Biochem Mol Biol. 2024; 12(4):631-642.

PMID: 39086582 PMC: 11288231. DOI: 10.61186/rbmb.12.4.631.

Exercise Training-Induced MicroRNA Alterations with Protective Effects in Cardiovascular Diseases.

Gao J, Song J, Yan Y, Gokulnath P, Vulugundam G, Li G Rev Cardiovasc Med. 2024; 24(9):251.

PMID: 39076378 PMC: 11270073. DOI: 10.31083/j.rcm2409251.

Expression Patterns of MiR-125a and MiR-223 and Their Association with Diabetes Mellitus and Survival in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.

Gager G, Eyileten C, Postula M, Nowak A, Gasecka A, Jilma B Biomedicines. 2023; 11(4).

PMID: 37189736 PMC: 10136270. DOI: 10.3390/biomedicines11041118.

miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives.

Sessa F, Salerno M, Esposito M, Cocimano G, Pomara C Int J Mol Sci. 2023; 24(6).

PMID: 36982265 PMC: 10048938. DOI: 10.3390/ijms24065192.

References

Dong L, Mintz G, Witzenbichler B, Metzger D, Rinaldi M, Duffy P . Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). Am J Cardiol. 2015; 115(7):860-6. DOI: 10.1016/j.amjcard.2015.01.008. View

Valmiki S, Ahuja V, Puri N, Paul J . miR-125b and miR-223 Contribute to Inflammation by Targeting the Key Molecules of NFκB Pathway. Front Med (Lausanne). 2020; 6:313. PMC: 6990118. DOI: 10.3389/fmed.2019.00313. View

Baumann A, Mishra A, Worthley M, Nelson A, Psaltis P . Management of multivessel coronary artery disease in patients with non-ST-elevation myocardial infarction: a complex path to precision medicine. Ther Adv Chronic Dis. 2020; 11:2040622320938527. PMC: 7331770. DOI: 10.1177/2040622320938527. View

Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic B, Hofman F . Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol. 2001; 116(1):62-73. DOI: 10.1016/s0165-5728(01)00280-6. View

Tao Y, Wang M, Wang M, Ma Y, Bai L, Feng P . Quantification of circulating miR-125b-5p predicts survival in chronic hepatitis B patients with acute-on-chronic liver failure. Dig Liver Dis. 2018; 51(3):412-418. DOI: 10.1016/j.dld.2018.08.030. View

Ma H, Wang X, Ha T, Gao M, Liu L, Wang R . MicroRNA-125b Prevents Cardiac Dysfunction in Polymicrobial Sepsis by Targeting TRAF6-Mediated Nuclear Factor κB Activation and p53-Mediated Apoptotic Signaling. J Infect Dis. 2016; 214(11):1773-1783. PMC: 5144735. DOI: 10.1093/infdis/jiw449. View

Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L . Immune and Inflammation in Acute Coronary Syndrome: Molecular Mechanisms and Therapeutic Implications. J Immunol Res. 2020; 2020:4904217. PMC: 7450309. DOI: 10.1155/2020/4904217. View

Schulte C, Molz S, Appelbaum S, Karakas M, Ojeda F, Lau D . miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease. PLoS One. 2016; 10(12):e0145930. PMC: 4699820. DOI: 10.1371/journal.pone.0145930. View

Eyileten C, Wicik Z, Keshwani D, Aziz F, Aberer F, Pferschy P . Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study. Cardiovasc Diabetol. 2022; 21(1):79. PMC: 9123651. DOI: 10.1186/s12933-022-01517-5. View

10.

Gager G, von Lewinski D, Sourij H, Jilma B, Eyileten C, Filipiak K . Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure. Biomed Pharmacother. 2021; 143:112169. DOI: 10.1016/j.biopha.2021.112169. View

11.

Czajka P, Fitas A, Jakubik D, Eyileten C, Gasecka A, Wicik Z . MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review. Front Physiol. 2021; 12:652579. PMC: 8081881. DOI: 10.3389/fphys.2021.652579. View

12.

Fu G, Brkic J, Hayder H, Peng C . MicroRNAs in Human Placental Development and Pregnancy Complications. Int J Mol Sci. 2013; 14(3):5519-44. PMC: 3634453. DOI: 10.3390/ijms14035519. View

13.

Chistiakov D, Orekhov A, Bobryshev Y . Vascular smooth muscle cell in atherosclerosis. Acta Physiol (Oxf). 2015; 214(1):33-50. DOI: 10.1111/apha.12466. View

14.

Saadatian Z, Nariman-Saleh-Fam Z, Bastami M, Mansoori Y, Khaheshi I, Alipour Parsa S . Dysregulated expression of STAT1, miR-150, and miR-223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis. J Cell Biochem. 2019; 120(12):19810-19824. DOI: 10.1002/jcb.29286. View

15.

Shi G, Zhang X, Chen Y, Ma S, Bai W, Yin Y . Prognostic Significance of Serum miR-22, miR-125b, and miR-15b in Non-Small Cell Lung Cancer Patients. Clin Lab. 2020; 66(6). DOI: 10.7754/Clin.Lab.2019.191129. View

16.

Zhang B, Wang L, Zhou Y . RETRACTED: Elevated microRNA-125b promotes inflammation in rheumatoid arthritis by activation of NF-κB pathway. Biomed Pharmacother. 2017; 93:1151-1157. DOI: 10.1016/j.biopha.2017.07.042. View

17.

Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M . Interplay between miRNAs and human diseases. J Cell Physiol. 2017; 233(3):2007-2018. DOI: 10.1002/jcp.25854. View

18.

Ye D, Lou G, Li A, Dong F, Chen G, Xu W . MicroRNA‑125a‑mediated regulation of the mevalonate signaling pathway contributes to high glucose‑induced proliferation and migration of vascular smooth muscle cells. Mol Med Rep. 2020; 22(1):165-174. PMC: 7248521. DOI: 10.3892/mmr.2020.11077. View

19.

Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

20.

Atashbasteh M, Mortaz E, Mahdaviani S, Jamaati H, Allameh A . Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors. Allergy Asthma Clin Immunol. 2021; 17(1):51. PMC: 8276852. DOI: 10.1186/s13223-021-00556-z. View